New hope for pancreatic cancer: phase 3 trial launches
Disease control
Recruiting now
This study tests a new chemotherapy combination (paclitaxel polymeric micelles plus gemcitabine) against the current standard treatment for metastatic pancreatic cancer. About 416 adults who have not had prior treatment for their advanced cancer will take part. The goal is to see…
Phase: PHASE3 • Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 19:43 UTC